ארזרה 1000 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OFATUMUMAB 20 MG/ML
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
L01XC10
Pharmaceutical form:
CONCENTRATE FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
GLAXO OPERATIONS (UK) LIMITED
Therapeutic group:
OFATUMUMAB
Therapeutic indications:
Treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab
Authorization date:
2012-10-01
